Neuren Pharmaceuticals | NEU - Ebitda

Stock Price
11.40
Daily Change
-0.17 -1.47%
Monthly
-12.38%
Yearly
-7.32%
Q1 Forecast
11.51

Neuren Pharmaceuticals reported AUD11.14M in EBITDA for its fiscal semester ending in December of 2025.





Ebitda Change Date
Akebia Therapeutics USD 14.03M 17.19M Mar/2025
Alaunos Therapeutics USD -21.02M 1.33M Mar/2021
Avita Medical AUD -9.69M 12.21M Dec/2025
Clinuvel Pharmaceuticals AUD 27.55M 12.65M Jun/2025
Dianthus Therapeutics USD -40.19M 5.36M Sep/2025
Genetic Signatures AUD -7.11M 970K Dec/2024
Ionis Pharmaceuticals USD -157.12M 307.36M Sep/2025
Medical Developments International AUD 1.78M 3.78M Dec/2024
Neuren Pharmaceuticals AUD 11.14M 165.56M Dec/2025
Organon & Co USD 383M 135M Dec/2025
Paradigm Biopharmaceuticals AUD -5.86M 3.79M Dec/2024
PYC Therapeutics AUD -22.79M 1.5M Dec/2025
Starpharma Holdings AUD -4.85M 1.73M Dec/2024
Tectonic Therapeutic USD -13.48M 5.73M Dec/2024
Telix Pharmaceuticals AUD 18.42M 14.82M Dec/2025
Viatris USD 1B 151.5M Dec/2025
Xeris Pharmaceuticals USD 17.42M 8.83M Sep/2025